Temperature-stable tuberculosis vaccine safe, prompts immune response in first-in-human trial

Clinical trial finds temperature-stable TB vaccine safe, prompts immune response

LOS ANGELES, March 6 (Xinhua) -- A clinical trial testing a freeze-dried, temperature-stable experimental tuberculosis (TB) vaccine in healthy adults found that it was safe and stimulated both antibodies and responses from the cellular arm of the immune system, the U.S. National Institutes of Health (NIH) announced on Monday. Read full story

Study Finds Temperature-Stable Tuberculosis (TB) Vaccine Safe and Effective

A clinical trial testing a freeze-dried, temperature-stable experimental tuberculosis (TB) vaccine in healthy adults found that it was safe and stimulated both antibodies and responses from the cellular arm of the immune system. The Phase 1 trial was supported by the National Institute of Allergy an

Temperature-stable tuberculosis vaccine safe, prompts immune response in first-in-human trial

A clinical trial testing a freeze-dried, temperature-stable experimental tuberculosis (TB) vaccine in healthy adults found that it was safe and stimulated both antibodies and responses from the cellular arm of the immune system. The Phase 1 trial was supported by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health. A non-temperature stable form of the candidate previously had been tested in

Temperature-stable TB vaccine safe, prompts immune response in NIH-supported study

A clinical trial testing a freeze-dried, temperature-stable experimental tuberculosis (TB) vaccine in healthy adults found that it was safe and stimulated both

Temperature-Stable TB Vaccine Safe, Prompts Immune Response in NIH-Supported Study – Washington DC Maryland Virginia Biotech Networks

The Access to Advanced Health Institute Reports Encouraging Results of First-In-Human Trial of Its Temperature-Stable Tuberculosis Vaccine Candidate – Washington Oregon Biotech Networks | Seattle, Portland and regional news, jobs, and events